
Bio-Techne Corp. Stock Underperforms Friday When Compared To Competitors

I'm PortAI, I can summarize articles.
Bio-Techne Corp.'s stock fell 2.90% to $58.51 on Friday, underperforming compared to competitors like Amgen Inc. and BioMarin Pharmaceutical Inc. Despite a grim trading session, Bio-Techne's trading volume exceeded its 50-day average. The stock is 26.20% below its 52-week high of $79.28.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

